Skip to main content
SpringerLink
Log in

Racecadotril

A Viewpoint by Herbert L. DuPont

  • Adis New Drug Profile
  • Guest Commentary
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Silberschmidt G, Schick MT, Steffen R, et al. Treatment of travellers’ diarrhoea: zaldaride compared with loperamide and placebo. Euro J Gastroenterol Hepatol 1995; 7: 871–5

    CAS  Google Scholar 

  2. Dicesare D, DuPont HL, Mathewsson JJ, et al. A double-blind, randomised, placebo-controlled study of SP-303 (Provir) in the symptomatic treatment of acute diarrhoea among travellers to Mexico and Jamaica [abstract no. 32]. Infectious Diseases Society of America, 36th Annual Meeting; 1998 Nov 13; Denver (CO)

Download references

Author information

Authors and Affiliations

  1. Internal Medicine Service, St Lukes Episcopal Hospital, Houston, Texas, USA

    Herbert L. DuPont

Authors
  1. Herbert L. DuPont
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

DuPont, H.L. Racecadotril. Drugs 59, 836–837 (2000). https://doi.org/10.2165/00003495-200059040-00012

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-200059040-00012

Search

Navigation